# Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD

> **NCT05881239** · — · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 250 (estimated)

## Conditions studied

- Subjective Cognitive Concerns
- Mild Cognitive Impairment
- Mild Behavioral Impairment
- Healthy Aging

## Interventions

- **DEVICE:** AROMHA Brain Health Test

## Key facts

- **NCT ID:** NCT05881239
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-09
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05881239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05881239, "Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT05881239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*